Related Experiment Videos
Secondary organ dysfunction. From clinical perspectives to molecular mediators
M D Cipolle1, M D Pasquale, F B Cerra
1Department of Surgery, University of Minnesota Hospital and Clinic, Minneapolis.
Critical Care Clinics
|April 1, 1993
Summary
The body
Area of Science:
- Critical care medicine
- Immunology
- Pathophysiology
Background:
- Systemic inflammatory response syndrome (SIRS) and organ dysfunction result from the body's reaction to injury.
- Understanding the complex mechanisms of this injury-response cascade is crucial for effective treatment.
- Key mediators like cytokines and cellular interactions play significant roles.
Purpose of the Study:
- To outline the clinical manifestations of the injury-response cascade.
- To explore the roles of various inflammatory mediators and cellular interactions.
- To review current and novel therapeutic strategies for managing this syndrome.
Main Methods:
- Review of clinical manifestations of the injury-response cascade.
- Exploration of the roles of cytokines, eicosanoids, platelet-activating factor, nitric oxide, oxygen-free radicals, and leukocyte-endothelial interactions.
- Review of goal-directed therapy including source control, resuscitation, and metabolic support.
Main Results:
- Detailed exploration of inflammatory mediators and cellular interactions involved in the injury-response cascade.
- Review of established goal-directed therapies for managing systemic inflammation and organ dysfunction.
- Description of emerging therapies such as monoclonal antibodies and immunomodulated nutrition.
Conclusions:
- Novel therapies, including monoclonal antibodies and immunomodulated nutrition, show promise for improving outcomes.
- Effective management requires a comprehensive approach addressing inflammation and organ support.
- Further research into these new therapies is warranted to combat this fatal syndrome.